Eurofins moves expanded biopharma testing to new Scottish facility
Eurofins has expanded capacity at its new facility in Livingstone, Scotland, where it will move its biopharmaceutical product testing business.
Archives for November 16, 2017
Acorda reports sepsis-related deaths in late-stage Parkinson’s drug trial
Acorda Therapeutics has halted enrolment for a trial of its Parkinson’s disease candidate tozadenant after the emergence of serious adverse events, including five deaths.
Question of characters: Longer tweets opportunity for #pharma promotion
Pharma firms making product benefit claims on Twitter must incorporate risk information within the same tweet regardless of character space limitations, says the US FDA.
Treat and trace? Sensor-embedded pill gains US approval
Otsuka Pharmaceutical’s pill embedded with a sensor that digitally verifies if patients have taken their medication has received US approval for mental illness indications.